GIANT BIOGENE Officially Listed on the Hong Kong Stock Exchange

In November 2022, GIANT BIOGENE was officially listed on the main board of the Hong Kong Stock Exchange under the stock code “2367”, becoming the “first collagen stock” with a market value of approximately RMB 27.4 billion yuan (USD $3.85 billion). Currently, GIANT BIOGENE has created eight major brands covering efficacious skin care products, medical dressings, and health food products, including a product portfolio of 105 SKUs and a product pipeline of 103 products in development, with a net profit margin of over 50% from 2019 to 202. Moreover, GIANT BIOGENE planned 5 capacity expansion projects with a total investment of RMB 1.5 billion yuan (USD $210 million). (Source: 163.com)

Visit HPA-China’s Information Hub, CLICK HERE